What's being worked on now is 3D Bioprinting where you can use what's called Bioink and you can actually print tissue.

Definitely by the end of the decade, we'll be able to use 3D Bioprinters to re-go organ.

So that'll be a really amazing breakthrough, I think.

And it sounds like science fiction, but all the stuff is already happening in clinical trials and animal studies.

So it's just like a pretty predictable roadmap to see where there's going to be in like by 2030.

Dr. Adele Khan, welcome to my podcast.

Thanks for having me.

Before we get started, can you give a brief description about what it is you do and who you are?

Yeah, so I'm a regenerative medicine doctor.

So what I do is I treat people using stem cells and plasma technology.

So instead of trying to get people better through drugs and surgery,

we try to repair their tissue back to a natural state or previous state before the injury.

That's my main specialty, but now because regenerative medicine, as we're going to, has evolved so much,

it's not just treating pain and injuries anymore.

That's what I started traditionally, but now it's evolved into so much more.

And I'm doing like clinical trials in different areas and using stem cells for like a broad range of applications.

Okay, this is very cool.

Who's your average client, do you think, or patient?

Well, it ranges from, you know, like I've had literally like, you know, moms who couldn't pick up their kids

and were in so much pain and they couldn't function all the way up to like the richest man in Dubai and who built the whole city.

Or, you know, some of the rulers of these kingdoms and stuff like that.

So it really does range and the reason is because there are, you know,

...